Loading...
Merus N.V.
MRUS•NASDAQ
Healthcare
Biotechnology
$66.82
$1.13(1.72%)
Merus N.V. (MRUS) Financial Performance & Income Statement Overview
Review Merus N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-17.78%
↓ 17.78%
Operating Income Growth
-73.79%
↓ 73.79%
Net Income Growth
-38.97%
↓ 38.97%
Operating Cash Flow Growth
-30.68%
↓ 30.68%
Operating Margin
-549.95%
↓ 549.95%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-506.73%
↓ 506.73%
ROE
-41.18%
↓ 41.18%
ROIC
-46.90%
↓ 46.90%
Merus N.V. (MRUS) Income Statement & Financial Overview
Review Merus N.V.'s (MRUS) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $26.49M | $9.14M | $11.77M | $7.33M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $9.14M | $11.77M | $7.33M |
| Gross Profit Ratio | $0.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $80.12M | $74.43M | $63.24M | $49.12M |
| SG&A Expenses | $22.11M | $23.37M | $20.77M | $21.95M |
| Operating Expenses | $102.23M | $97.79M | $84.004M | $71.07M |
| Total Costs & Expenses | $0.00 | $99.65M | $84.004M | $71.71M |
| Interest Income | $0.00 | $8.49M | $10.25M | $7.13M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $589000.00 | $635000.00 | $640000.00 |
| EBITDA | $0.00 | -$88.06M | -$96.29M | -$59.50M |
| EBITDA Ratio | $0.00 | -$9.63 | -$8.18 | -$8.11 |
| Operating Income | $0.00 | -$88.65M | -$72.23M | -$64.37M |
| Operating Income Ratio | $0.00 | -$9.70 | -$6.14 | -$8.78 |
| Other Income/Expenses (Net) | $0.00 | $59.49M | -$24.70M | $12.37M |
| Income Before Tax | -$94.62M | -$29.16M | -$96.93M | -$47.73M |
| Income Before Tax Ratio | -$3.57 | -$3.19 | -$8.23 | -$6.51 |
| Income Tax Expense | $1.85M | $1.76M | $2.98M | $2.32M |
| Net Income | -$96.47M | -$30.92M | -$99.91M | -$50.04M |
| Net Income Ratio | -$3.64 | -$3.38 | -$8.49 | -$6.83 |
| EPS | -$1.40 | -$0.48 | -$1.46 | -$0.81 |
| Diluted EPS | -$1.40 | -$0.48 | -$1.46 | -$0.81 |
| Weighted Avg Shares Outstanding | $69.02M | $68.83M | $68.25M | $61.85M |
| Weighted Avg Shares Outstanding (Diluted) | $69.02M | $68.83M | $68.25M | $61.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan